CymitQuimica logo

CAS 22717-41-5

:

3H-Pyrazol-3-one, 4-ethyl-2,4-dihydro-5-methyl-2-phenyl-

Description:
3H-Pyrazol-3-one, 4-ethyl-2,4-dihydro-5-methyl-2-phenyl- (CAS 22717-41-5) is a heterocyclic organic compound characterized by its pyrazolone structure, which features a five-membered ring containing two nitrogen atoms. This compound typically exhibits a range of chemical properties, including potential reactivity due to the presence of the carbonyl group and the nitrogen atoms, which can participate in various chemical reactions such as nucleophilic attacks. The ethyl and phenyl substituents contribute to its hydrophobic character, influencing its solubility in organic solvents. Additionally, the presence of the methyl group can affect its steric hindrance and electronic properties. Compounds of this class may exhibit biological activity, making them of interest in medicinal chemistry. Their stability and reactivity can vary based on the specific substituents and the overall molecular structure. Overall, 3H-Pyrazol-3-one derivatives are valuable in synthetic organic chemistry and may have applications in pharmaceuticals and agrochemicals.
Formula:C12H14N2O
Sort by

Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 2 products.
  • DP-1

    Controlled Product
    CAS:
    <p>Applications DP-1 is a reagent used in the metal-catalyzed and highly enantioselective formation of complex pyrazolone derivatives.<br>References Tao, Z., et. al.: J. Am. Chem. Soc., 135, 9255 (2013);Wang, Z., et. al.: Angew. Chem. Int. Ed. Engl., 50, 4928 (2011);Yang, Z., et. al.: Org. Lett., 13, 596 (2011)<br></p>
    Formula:C12H14N2O
    Color and Shape:Neat
    Molecular weight:202.252

    Ref: TR-D585400

    100mg
    1,022.00€
  • DP-1

    CAS:
    <p>DP-1 is a potent anticancer agent that targets the cell cycle machinery in human cancer cells. It has been shown to inhibit cyclin-dependent kinases, leading to apoptosis and cell death in various cancer cell lines. DP-1 specifically binds to a protein that regulates the cell cycle, preventing its activation and inhibiting tumor growth. This inhibitor is highly effective against multiple types of cancer and has been tested on human cancer cell lines with promising results. DP-1 offers a new approach to treating cancer by targeting the underlying mechanisms of tumor growth, making it an exciting development in the field of oncology.</p>
    Formula:C12H14N2O
    Purity:Min. 95%
    Molecular weight:202.25 g/mol

    Ref: 3D-XAA71741

    250mg
    894.00€